NCT06254157View on ClinicalTrials.gov

Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2027

Conditions
Generalized Anxiety Disorder
Trial Locations (1)

94107

Power Life Sciences, San Francisco

Sponsors
All Listed Sponsors
lead

Power Life Sciences Inc.

INDUSTRY

NCT06254157 - Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials | Biotech Hunter | Biotech Hunter